Activated JNK releases Beclin-1 by phosphorylating Bcl-2 and B-cell lymphoma-extra large (Bcl-XL), thereby activating autophagy and enhancing cellular resistance to apoptosis in melanoma cells (Corazzari et al., 2015). This evidence concerns the gene BECN1 and melanoma.